Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group

Autor: Geoffroy Canlorbe, Emile Daraï, Charles Coutant, Pierre Alain Reboux, Marcos Ballester, Charles Henry Canova, Henri Azaïs, Olivier Graesslin, Pierre Collinet, Jean Levêque, Cyril Touboul, Sofiane Bendifallah, Alexandre Bricou, Lobna Ouldamer, Delphine Hudry, Cyrille Huchon, Martin Koskas, Vincent Lavoué, Catherine Uzan, Emilie Raimond

Publikováno v: Journal of Gynecologic Oncology
Journal of Gynecologic Oncology, Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology, 2019, 30 (4), pp.e53. ⟨10.3802/jgo.2019.30.e53⟩
Journal of Gynecologic Oncology, 2019, 30 (4), pp.e53. ⟨10.3802/jgo.2019.30.e53⟩

International audience; Objective - According to recent European Society of Medical Oncology, European Society of Gynaecological Oncology and European Society of Radiotherapy and Oncology guidelines, adjuvant vaginal brachytherapy (VB) is optional in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78c2f446f32bc3d9c58f482e64e1d4cb
https://hal-univ-rennes1.archives-ouvertes.fr/hal-02130805/document